Ocean Biomedical, Inc. (NASDAQ:OCEAW) Short Interest Update

Ocean Biomedical, Inc. (NASDAQ:OCEAW) was the target of a large decrease in short interest in December. As of December 15th, there was short interest totalling 39,900 shares, a decrease of 19.9% from the November 30th total of 49,800 shares. Based on an average trading volume of 34,600 shares, the short-interest ratio is currently 1.2 days.

Ocean Biomedical Stock Down 5.6 %

Shares of NASDAQ:OCEAW traded down $0.00 during trading on Monday, reaching $0.03. The company’s stock had a trading volume of 1,708 shares, compared to its average volume of 40,636. Ocean Biomedical has a 12 month low of $0.02 and a 12 month high of $0.70. The firm’s 50 day simple moving average is $0.04 and its two-hundred day simple moving average is $0.04.

About Ocean Biomedical

Ocean Biomedical, Inc, a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.